MedWand®'s Latest Regulatory Green Light Enables Use of the Sensor Based Medical Device for Comprehensive Patient Assessment Internationally
Wisconsin Eagle/10260951

RANCHO SANTA MARGARITA, Calif. - WisconsinEagle -- MedWand Solutions, Inc., the ultimate healthcare solution and a pioneer in telehealth technology, is pleased to announce its recent regulatory clearance in Thailand. This latest approval allows MedWand to empower a broader spectrum of clinicians and healthcare providers, enabling them to elevate care standards and grant easier access to healthcare services.

"The regulatory clearance in Thailand reflects our dedication to making comprehensive remote healthcare services accessible worldwide," shared MedWand Senior Director of International Business Development, Stuart English. "We are thrilled to bring MedWand to Thailand, addressing healthcare needs and creating new opportunities for collaboration with international partners."

More on Wisconsin Eagle

• Strategic Partnerships with Defiant Space Corp and Emtel Energy USA Powerfully Enhance Solar Tech Leader with NASA Agreements: Ascent Solar $ASTI
• 120% Revenue Surge with Four Straight Profitable Quarters Signal a Breakout in the Multi-Billion Dollar Homebuilding Market: Innovative Designs $IVDN
• Leading Venture Capital Firms Recognize Wzzph Exchange's Technical Architecture and Security Framework as Industry Benchmark
• DivX Unveils Major DivX Software Update: Seamless Video Sharing and Customizable Playback Now Available
• Nespolo Mechanical Helps New Mexico Families Save Thousands on Heating Costs This Fall

MedWand is the ultimate healthcare solution, seamlessly integrating traditional tools and Bluetooth connectivity for vitals capture and remote patient evaluations to enhance efficiency, convenience, and access to care. Following its FDA clearance and product launch in the United States in 2022, MedWand has gained significant traction with major US health systems, telehealth companies, large private practices, and employers.

"Following thorough research, we have identified the MedWand multi-sensor vitals capture device, together with the VirtualCare telemedicine platform, as the pivotal components essential for revolutionizing telemedicine services. This combination is poised to facilitate advanced clinical care accessible to patients regardless of their location, eliminating the necessity for hospital visits," commented Dr. Supornchai Kongpatanakul, President of Kitmeechai Trading Co., Ltd.

The device's versatility and ease of use make it a valuable asset for both healthcare professionals and patients. Transforming the traditional understanding of telehealth, MedWand combines multiple vitals sensors into one, handheld, lightweight device. Data collected can include core temperature, blood oxygen saturation, and pulse rate, heart, lung and abdominal auscultations, electrocardiogram*, and high definition otoscopic, oropharynx, and dermatoscopic exam images. Through approved 3rd party Bluetooth peripherals, MedWand can also seamlessly capture blood pressure, glucometer, spirometry, and weight data.

More on Wisconsin Eagle

• Leading Digital Finance Platform YNQTL Launches Revolutionary Web3 Digital Asset Trading Platform
• IDCXS Addresses Crypto Trading Pain Points with 2 Million TPS Processing and Multi-Layer Security Architecture
• Bridging Traditional Finance and Web3 Innovation: BLFCW Announces Strategic Vision for Regulated Web3 Economy
• NKSCX Responds to "Coordinated Smear Campaign" as Anonymous Critics Emerge Following Regulatory Milestones
• Broadway Gala Honored Also an Italian

For more information on MedWand visit www.medwand.com. To schedule a private demonstration or to request a formal quotation please contact MedWand at https://www.medwandhealth.com/contact.

*Electrocardiogram feature is currently awaiting US FDA 510(k) clearance.